News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Andrea Necchi: Pleased to see the interim results of SURE01 trial slated for presentation at ASCO24
Photo of Andrea Necchi from www.hsr.it
Apr 28, 2024, 19:14

Andrea Necchi: Pleased to see the interim results of SURE01 trial slated for presentation at ASCO24

Andrea Necchi, Associate Professor at Vita-Salute San Raffaele University, shared on LinkedIn:

“Very pleased to see the interim results of SURE01 trial (neoadjuvant sacituzumab govitecan prior to cystectomy in MIBC) slated for presentation at ASCO24 with preliminary biomarkers and bladder-saving results.”

Perioperative sacituzumab govitecan (SG) alone or in combination with pembrolizumab (Pembro) for patients with muscle-invasive urothelial bladder cancer (MIBC): SURE-01/02 interim results

Authors: Antonio Cigliola, Marco Moschini, Valentina Tateo, Chiara Mercinelli, Damiano Patanè, Emanuele Crupi, Renzo Colombo, Vincenzo Scattoni, Giorgio Brembilla, Maurizio Colecchia, Francesco Montorsi, and Andrea Necchi

Andrea Necchi

Source: Andrea Necchi/LinkedIn

Andrea Necchi Antonio Cigliola ASCO ASCO24 cancer Chiara Mercinelli Damiano Patanè Emanuele Crupi Francesco Montorsi Giorgio Brembilla Marco Moschini Maurizio Colecchia MIBC muscle invasive bladder cancer OncoDaily Oncology Renzo Colombo Sacituzumab govitecan SURE01 trial Valentina Tateo Vincenzo Scattoni Vita-Salute San Raffaele University
Special Coverage
Science
Dec 21, 2024, 13:12
Myeloma Paper of the Day, December 21st, suggested by Robert Orlowski
Blog
Dec 21, 2024, 13:06
Varsha Gupta: Fertility preservation causes no significant delay in cancer treatment initiation and outcomes
Cancer Types
Dec 21, 2024, 13:05
Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment
Insight
Dec 21, 2024, 12:45
Practical treatment strategies and novel therapies for HR positive/HER2 negative advanced breast cancer
Insight
Dec 21, 2024, 12:39
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer
Blog
Dec 21, 2024, 12:18
NCI Symposium on Translational Technology for Global Health
Blog
Dec 21, 2024, 12:14
Paolo Tarantino: Ending of a terrific 3-year cycle of PhD at The University of Milan
Blog
Dec 21, 2024, 11:52
Gevorg Tamamyan's first message as New POEM President
Blog
Dec 21, 2024, 11:30
Kyaw Thein: Tissue-Agnostic Drug Development in Cancer
Dialogues
Dec 21, 2024, 11:29
Beyond the Cancer Diagnosis: Dialogue with Marianne Arab, Hosted by Adrian Pogacian
Blog
Dec 21, 2024, 11:27
Aleix Prat: Carlos Fernandez de Larrea has been appointed as a Professor at the University of Barcelona
Blog
Dec 21, 2024, 11:25
Canadian Cancer Society - Natalie Wild's caregiver story